琥珀酸美托洛尔缓释片和酒石酸美托洛尔片对急性心肌梗死患者心率的影响Comparison of effects of metoprolol succinate sustained-release tablets and metoprolol tartrate tablets on heart rates of patients with acute myocardial infarction
王蛟龙;陈莉;齐国先;
摘要(Abstract):
目的比较琥珀酸美托洛尔缓释片和酒石酸美托洛尔片对急性心肌梗死患者心率的影响。方法选择急性心肌梗死患者76例,在除外应用美托洛尔禁忌后,按1∶2比例随机分配到琥珀酸美托洛尔缓释片组25例和酒石酸美托洛尔片组51例。前者给予琥珀酸美托洛尔23.75 mg,日1次口服,后者给予酒石酸美托洛尔12.5 mg,日2次口服。在此基础上,两组均常规予阿司匹林、氯吡格雷、ACEI及他汀类药物治疗,分别记录用药前和用药后24、48、72 h静息状态的心率,比较用药后心率下降的程度和趋势。结果琥珀酸美托洛尔缓释片组在用药后24、48、72 h 3个时间点的心率分别下降了0、1%、9%,次数下降了0.5次/min、1.6次/min、7.6次/min,酒石酸美托洛尔片组心率分别下降了3%、5%、6%,次数下降了3.5次/min、4.1次/min、5.7次/min。P均<0.05,认为不同时间点上患者心率的差异有统计学意义;而因素心率和剂型的交互作用的P值均>0.05,尚不能认为剂型和心率有交互作用。两组患者服药后72 h内,心率变化的趋势无统计学意义,P均>0.05。结论急性心肌梗死患者应用琥珀酸美托洛尔缓释片或酒石酸美托洛尔片,72 h内心率降低的差异有统计学意义,但两组服药后72 h内,心率的降低程度差异无统计学意义,而且72 h内两组心率下降的趋势,差异也无统计学意义。
关键词(KeyWords): 琥珀酸美托洛尔缓释片;酒石酸美托洛尔片;急性心肌梗死
基金项目(Foundation):
作者(Authors): 王蛟龙;陈莉;齐国先;
DOI: 10.14053/j.cnki.ppcr.2011.04.016
参考文献(References):
- [1]McAlister FA,Wiebe N,Ezekowitz JA,et al.Meta-analysis:beta-blocker dose,heart rate reduction,and death in patientswith heart failure[J].Ann Intern Med,2009,150(11):784-794.
- [2]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用专家共识[J].中华心血管病杂志,2009,37(3):195-209.
- [3]Irani F,Herial N,Colyer WR Jr.Impact of an acute coronarysyndrome pathway in achieving target heart rate and utilizationof evidence-based doses of beta-blockers[J].Am J Ther,2011.Feb10[Epub ahead of print].
- [4]Abu Ruz ME,Lennie TA,Moser DK.Effects of beta-blockersand anxiety on complication rates after acute myocardial infarc-tion[J].Am J Crit Care,2011,20(1):67-73,quiz74.
- [5]Cooney MT,Vartiainen E,Laatikainen T,et al.Elevated restingheart rate is an independent risk factor for cardiovascular dis-ease in healthy men and women[J].Am Heart J,2010,159(4):612-619,e3.
- [6]Tardif JC.Heart rate as a treatable cardiovascular risk factor[J].Br Med Bull,2009,90:71-84.
- [7]Fox K,Borer JS,Camm AJ,et al.Resting heart rate in cardio-vascular disease[J].J Am Coll Cardiol,2007,50(9):823-830.
- [8]Ibanez B,Cimmino G,Prat-Gonzalez S,et al.The cardioprotec-tion granted by metoprolol is restricted to its administration pri-or to coronary reperfusion[J].Int J Cardiol,2011,147(3):428-432.